Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
22 12 2020
Historique:
entrez: 22 12 2020
pubmed: 23 12 2020
medline: 27 1 2021
Statut: ppublish

Résumé

The number of cancer survivors who develop new cancers is projected to increase, but comprehensive data on the risk of subsequent primary cancers (SPCs) among survivors of adult-onset cancers are limited. To quantify the overall and cancer type-specific risks of SPCs among adult-onset cancer survivors by first primary cancer (FPC) types and sex. A retrospective cohort study from 12 Surveillance, Epidemiology, and End Results registries in the United States, that included 1 537 101 persons aged 20 to 84 years diagnosed with FPCs from 1992-2011 (followed up until December 31, 2017) and who survived at least 5 years. First primary cancer. Incidence and mortality of SPCs per 10 000 person-years; standardized incidence ratio (SIR) and standardized mortality ratio (SMR) compared with those expected in the general population. Among 1 537 101 survivors (mean age, 60.4 years; 48.8% women), 156 442 SPC cases and 88 818 SPC deaths occurred during 11 197 890 person-years of follow-up (mean, 7.3 years). Among men, the overall risk of developing any SPCs was statistically significantly higher for 18 of the 30 FPC types, and risk of dying from any SPCs was statistically significantly higher for 27 of 30 FPC types as compared with risks in the general population. Among women, the overall risk of developing any SPCs was statistically significantly higher for 21 of the 31 FPC types, and risk of dying from any SPCs was statistically significantly higher for 28 of 31 FPC types as compared with risks in the general population. The highest overall SIR and SMR were estimated among survivors of laryngeal cancer (SIR, 1.75 [95% CI, 1.68-1.83]; incidence, 373 per 10 000 person-years) and gallbladder cancer (SMR, 3.82 [95% CI, 3.31-4.39]; mortality, 341 per 10 000 person-years) among men, and among survivors of laryngeal cancer (SIR, 2.48 [95% CI, 2.27-2.72]; incidence, 336 per 10 000 person-years; SMR, 4.56 [95% CI, 4.11-5.06]; mortality, 268 per 10 000 person-years) among women. Substantial variation existed in the associations of specific types of FPCs with specific types of SPC risk; however, only a few smoking- or obesity-associated SPCs, such as lung, urinary bladder, oral cavity/pharynx, colorectal, pancreatic, uterine corpus, and liver cancers constituted considerable proportions of the total incidence and mortality, with lung cancer alone accounting for 31% to 33% of mortality from all SPCs. Among survivors of adult-onset cancers in the United States, several types of primary cancer were significantly associated with greater risk of developing and dying from an SPC, compared with the general population. Cancers associated with smoking or obesity comprised substantial proportions of overall SPC incidence and mortality among all survivors and highlight the importance of ongoing surveillance and efforts to prevent new cancers among survivors.

Identifiants

pubmed: 33351041
pii: 2774406
doi: 10.1001/jama.2020.23130
pmc: PMC7756242
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2521-2535

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : ErratumIn

Références

Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):224-33
pubmed: 23102695
Radiat Oncol J. 2018 Jun;36(2):85-94
pubmed: 29983028
Breast. 2017 Jun;33:1-7
pubmed: 28254640
Lancet Oncol. 2009 Apr;10(4):321-2
pubmed: 19350698
Nat Rev Clin Oncol. 2013 May;10(5):289-301
pubmed: 23529000
Int J Cancer. 2019 Jul 1;145(1):143-153
pubmed: 30613963
Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):963-970
pubmed: 28096199
Am J Epidemiol. 2003 Dec 1;158(11):1108-13
pubmed: 14630607
JAMA Oncol. 2018 Jan 1;4(1):48-53
pubmed: 28837714
JAMA Oncol. 2018 Jun 1;4(6):832-836
pubmed: 29167866
CA Cancer J Clin. 2016 Jan-Feb;66(1):43-73
pubmed: 26641959
J Oncol Pract. 2019 Nov;15(11):e916-e924
pubmed: 31265350
JAMA Oncol. 2019 Mar 1;5(3):318-325
pubmed: 30570657
J Cancer Surviv. 2019 Feb;13(1):66-74
pubmed: 30612253
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2006-14
pubmed: 21980008
J Clin Oncol. 2003 Jun 15;21(12):2232-3
pubmed: 12805320
Clin Sarcoma Res. 2012 Oct 04;2(1):18
pubmed: 23036235
Lancet HIV. 2018 Nov;5(11):e647-e655
pubmed: 30245004
JAMA Netw Open. 2020 Jul 1;3(7):e209072
pubmed: 32614423
J Clin Oncol. 2014 Dec 10;32(35):4004-11
pubmed: 25267739
CA Cancer J Clin. 2015 Nov-Dec;65(6):428-55
pubmed: 26348643
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1029-36
pubmed: 27371756
Breast Cancer Res Treat. 2012 Oct;135(3):647-54
pubmed: 22864804
Br J Cancer. 2019 Jan;120(2):256-268
pubmed: 30482913
Lancet Oncol. 2019 Apr;20(4):531-545
pubmed: 30797674
Prev Med. 2016 Sep;90:52-8
pubmed: 27370167
Cancer. 2016 Jan 1;122(1):116-23
pubmed: 26441212

Auteurs

Hyuna Sung (H)

Department of Data Science, American Cancer Society, Atlanta, Georgia.

Noorie Hyun (N)

Institute for Health and Equity, Medical College of Wisconsin, Milwaukee.

Corinne R Leach (CR)

Department of Population Science, American Cancer Society, Atlanta, Georgia.

K Robin Yabroff (KR)

Department of Data Science, American Cancer Society, Atlanta, Georgia.

Ahmedin Jemal (A)

Department of Data Science, American Cancer Society, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH